Frederic H. Moll - 21 Feb 2024 Form 4 Insider Report for Shockwave Medical, Inc.

Role
Director
Signature
/s/ Wade Estey, as attorney-in-fact for Frederic H. Moll
Issuer symbol
N/A
Transactions as of
21 Feb 2024
Net transactions value
-$15,443,412
Form type
4
Filing time
22 Feb 2024, 20:15:02 UTC
Previous filing
09 Feb 2024
Next filing
31 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale $1,644,122 -6,444 -1.9% $255.14 341,077 21 Feb 2024 Direct F1
transaction SWAV Common Stock Sale $4,213,961 -16,464 -4.8% $255.95 324,613 21 Feb 2024 Direct F2
transaction SWAV Common Stock Sale $3,637,855 -14,165 -4.4% $256.82 310,448 21 Feb 2024 Direct F3
transaction SWAV Common Stock Sale $2,232,220 -8,649 -2.8% $258.09 301,799 21 Feb 2024 Direct F4
transaction SWAV Common Stock Sale $688,807 -2,660 -0.88% $258.95 299,139 21 Feb 2024 Direct F5
transaction SWAV Common Stock Sale $1,436,782 -5,528 -1.8% $259.91 293,611 21 Feb 2024 Direct F6
transaction SWAV Common Stock Sale $1,275,312 -4,890 -1.7% $260.80 288,721 21 Feb 2024 Direct F7
transaction SWAV Common Stock Sale $314,352 -1,200 -0.42% $261.96 287,521 21 Feb 2024 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $254.43 to $255.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $255.43 to $256.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $256.43 to $257.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $257.43 to $258.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $258.43 to $259.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $259.44 to $260.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $260.45 to $261.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F8 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $261.54 to $262.40. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.